- Home
- ALT vs SPT Comparison
ALT vs SPT Comparison
Compare ALT & SPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALT | SPT |
|---|---|---|
| Founded | 1997 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 421.5M | 449.6M |
| IPO Year | 2005 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ALT | SPT |
|---|---|---|
| Price | $3.05 | $7.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 8 |
| Target Price | ★ $17.67 | $11.75 |
| AVG Volume (30 Days) | ★ 4.0M | 1.5M |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 25.37 | ★ 32.11 |
| EPS | N/A | ★ N/A |
| Revenue | $41,000.00 | ★ $457,547,000.00 |
| Revenue This Year | N/A | $8.86 |
| Revenue Next Year | N/A | $8.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 105.00 | 12.72 |
| 52 Week Low | $2.56 | $4.92 |
| 52 Week High | $6.44 | $21.53 |
Technical Indicators
Market Signals| Indicator | ALT | SPT |
|---|---|---|
| Relative Strength Index (RSI) | 58.83 | 59.47 |
| Support Level | $2.87 | $5.82 |
| Resistance Level | $3.09 | $8.31 |
| Average True Range (ATR) | 0.13 | 0.46 |
| MACD | 0.04 | 0.04 |
| Stochastic Oscillator | 81.57 | 88.86 |
Price Performance
Historical ComparisonAbout ALT Altimmune Inc.
Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About SPT Sprout Social Inc
Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. It has a centralized, secure and powerful platform that can scale horizontally across an organization to drive maximum business value. The firm generates majority revenue from software subscriptions. Geographically, the company operates in Americas, EMEA, and Asia Pacific, of which it derives maximum revenue from Americas.